Position in IMCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$141,890,963
-$21,025,382 QoQ
Shares Held
4,706,168
+0.3% QoQ
Ownership
9.25%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.43160465159765.ToString("F0")%
None 2.5683953484023516.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. IMCR ranks #29 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $141,890,963 | 4,706,168 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $162,916,345 | 4,693,643 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $173,689,694 | 4,780,889 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $132,221,980 | 4,213,575 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $181,928,130 | 6,131,720 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $195,203,122 | 6,617,055 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $219,430,166 | 7,048,833 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $216,233,482 | 6,380,451 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $373,572,550 | 5,747,270 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $294,637,580 | 4,312,611 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $203,105,977 | 3,913,410 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $221,581,578 | 3,695,490 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $166,875,275 | 3,375,309 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $122,869,767 | 2,152,966 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $31,671,966 | 674,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,231,174 | 1,265,912 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $40,136,533 | 1,342,359 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $48,420,493 | 1,414,150 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $39,000,418 | 1,052,075 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,383,542 | 291,512 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,530,028 | 247,358 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||